Click below to
read our newsletter:



Letters from Alumni: <Click here>
RENEWAL: Christian Treatment & Recovery is a Brookhaven Hospital program. For more information, contact us at:
Brookhaven Hospital
201 S. Garnett Rd.
Tulsa, OK 74128
888-298-HOPE
Fax: 918-438-8016
wecanhelp@brookhavenhospital.com
|
October 30, 20095:45 am
posted by Aric Thorpe, MHR
Advanced dementia often plagued with distressing symptoms and critical care interventions
The stages of advanced dementia are often plagued with intense and distressing symptoms as well as a variety of critical care interventions. Perhaps this information is not too awful surprising to clinicians and healthcare professionals; however, for families, understanding the end-stage realities of dementia can be the difference between a distressing and burdensome happening and a loving calm goodbye. Findings from a study reported in the October 14th issue of the New England Journal of Medicine found that often times end-stage dementia is associated with eating disorders and various infections. Out of the 323 patients with advance dementia in the study, 40% developed pneumonia, nearly half had a febrile episode, and nearly 85% suffered from eating problems during the 18 month period of observation. According to Susan L. Mitchel, MD, MPH, of the Hebrew Senior Life Institute for Aging Research in Boston, and colleagues, “…patients, families and healthcare providers must understand and be prepared to confront the end-stage of this disease, which is estimated to afflict more than 5 million Americans currently and is expected to afflict more than 13 million by 2050.” Click here to read an article from TIME that discusses this study more.
Link to this post
October 29, 20096:21 am
posted by Aric Thorpe, MHR
Tricyclic antidepressants are more likely to cause suicidal thoughts?
According to a study published online in BMC Medicine, tricyclic antidepressants are more likely to cause suicidal thoughts as compared to SSRI. According to the study, men taking nortriptyline were 2.4 times more likely to have suicidal thoughts than those taking Lexapro (SSRI compared). Nortiptyline was also associated with a 9.8 fold higher risk of suicidal ideation than the SSRI. According to Nader Perroud, MD, of Kings College London, and colleagues, the difference between the two drugs and prevalence of suicidal ideation is that nortiptyline acts primarily in the noradrenergic system; this system, when it is over active, is often associated with agitation and anxiety. The researchers put it this way, “suicidal idiation is more common in agitated and irritable types of depression… it is possible that nortiptyline may induce or worsen suicidal thoughts in some male subjects, possibly through an induction of this more agitated type of depression.” Click here to read an article from Pharma Times that discusses the findings more.
Link to this post
October 26, 20096:46 am
posted by Aric Thorpe, MHR
Cocaine vaccination causes hope
What will they come up with next? According to an article published in the October issue of the Archives of General Psychiatry a vaccine against cocaine was effective in nearly 40% of the drugs users. According to Thomas Kosten, MD, of Baylor College of Medicine in Houston and colleagues, in the randomized placebo-controlled study volunteers, who after receiving the vaccination reached a high level of antibodies, ended up using less cocaine than those whose response was lower. According to the researchers, “We didn’t expect to cure them in six months… in clinical practice, you’d probably give people a booster shot every two months.” This appears to be some very exciting news with a great deal of potential. I could see where this would be particularly beneficial to those that were trying to decrease their dependance on the illegal substance. Click here to read an article from TIME that discusses the study more.
Link to this post
October 22, 20099:57 am
posted by Aric Thorpe, MHR
OTC and Prescription Drug Use on the Rise
According to a study recently discussed at an meeting of the American Academy of Pediatrics, while the use of illegal drugs by adolescents has decline greatly in recent years, there has been an alarming increase in teens that are abusing over the counter (OTC) drugs and prescription drugs. According to the study, marijuana is still the most widely used drug by adolescents over the age of 12; however, pain relievers come in second closely. According to the National Survey on Drug Use and Health approximately 57% of adolescents ages 12 and over first used marijuana and 23% took other pain relievers as well. The most commonly abused pain relievers were oxycodone hydrochloride (OxyContin) and hydrocodone (Vicodin). According to Hoover Adger Jr., MD, MPH, a professor of pediatrics at Johns Hopkins, “Although illicit drug use is declining, now there seems to be a new threat, and that threat is the family medicine cabinet.” Click here to read an article from Medpage Today that discusses this study further.
Link to this post
October 21, 200910:10 am
posted by Aric Thorpe, MHR
Study says Omega-3 Fatty Acids do not prove to have an antidepressant effect
Fish oil has long received recognition for its various health benefits; however, a study published in the October 21st issue of the Journal of the American Medical Association found that the popular Omega-3 Fatty Acids do not prove to have an antidepressant effect. According to the authors, participants that were given fish oil did not show any differences in measures of depressive symptoms, remission or response, as compared to those that were given placebo. According to Robert M. Carney, PhD, of Washington University in St. Louis, and colleagues, “We had very high hopes for this,” he said, but “I certainly wouldn’t close the door on omega-3 in terms of its potential effects on depression.” The researchers had very high hopes as anticipated outcomes made a great deal of biological sense, Omega-3 Fatty Acids playing an essential role in the function of neurons. Perhaps studies over a longer duration are needed. Click here to read an article from WebMD that discusses this study more.
Link to this post
October 20, 200910:32 am
posted by Aric Thorpe, MHR
Codeine Crack Down
Aggressive pharmaceutical companies got a nasty message from the FDA warning about the illegal production of codeine in the form of an analgesic tab, the drug being a narcotic. The FDA’s crackdown on unapproved drugs began in June of 2006 as a part of an ongoing initiative. The following manufacturers were issued warning letters about further production of the tabs:
Codeine Sulfate Tablets, 30 mg, 60 mg from Cerovene Inc., Valley Cottage, N.Y.
Codeine Sulfate Tablets, 30 mg, 60 mg from Lehigh Valley Technologies Inc., Allentown, Penna.
Codeine Sulfate Tablets, 30 mg, 60 mg from Dava International Inc., Fort Lee, N.J.
Codeine Sulfate Tablets, 30 mg, 60 mg from Glenmark Generics Inc. USA, Mahwah, N.J.
According to Janet Woodcock, MD, director of the FDA Center for Drug Evaluation and Research, “Consumers deserve and expect that their drugs meet modern FDA standards for safety, effectiveness, labeling, and quality.” This does not mean, however, that the FDA will not issue temporary approvals of the drugs in the future in situations where there are shortages; the FDA does not foresee such issues. Click here to read an article from Medpage Today that discusses this study more.
Link to this post
October 16, 20095:06 pm
posted by Aric Thorpe, MHR
SSRIs during pregnancy may lead to problems
Findings from a study published in the October issue of Archives of Pediatrics and Adolescent Medicine have indicated that SSRI (selective serotonin re-uptake inhibitor) use during pregnancy may lead to issues for developing babies. According to the study, SSRI therapy during pregnancy could cause adverse neonatal outcomes in that those that took antidepressants among the population studied were more likely have a five-minute Apgar score of 7 or less (OR 4.44, 95% CI 2.58 to 7.63) and to be admitted to the NICU (OR 2.39, 95% CI 1.69 to 3.39). According to Najaaraq Lund, MD, of Aarhus University in Denmark and the Bandim Health Project in Bissau, Guinea-Bissau, and colleagues, “The study justifies increased awareness to the possible effects of intrauterine exposure to antidepressant… however, treatment of depression during pregnancy may be warranted and future studies need to distinguish between individual SSRIs to find the safest medication.” Click here to read an article from US News and World Report that discusses this study more.
Link to this post
October 15, 20096:16 am
posted by Aric Thorpe, MHR
Depressed? Switch to a Mediterranean diet
According to a study published in the October Archives of General Psychiatry, a Mediterranean diet may actually protect against factors causing depression. Countries that consume a majorly Mediterranean diet, which is largely composed of fruit, legumes, vegetables, and olive oil, have shown on average a lower lifetime prevalence of psychiatric disorders according to a Spanish study. Almudena Sanchez-Villegas, PhD, of the University of Las Palmas de Gran Canaria in Spain, and colleagues, relayed that after the participants were scored for their dietary practices, those that were found to fit into the constraints of what is considered to be a “Mediterranean diet” were found to be less likely to develop depression (HR 0.58, 95% CI 0.44 to 0.77); this was compared to those in the lowest quintile. Click here to read an article from the New York Times that discusses this study more.
Link to this post
October 14, 20097:46 am
posted by Aric Thorpe, MHR
Trauma during childhood shortens lifespan, researchers say
According to a study published in the October addition of the American Journal of Preventative Medicine, a cohort ACE study composed 16,908 adults between 1995 and 1997 found that individuals who had suffered traumatic childhood events were more likely to have a shortened lifespan; specifically, those who had experienced six or more traumatic events as children died on average twenty years earlier than those who had not. According to the CDC’s David Brown, DSc, MScPH, and colleagues, “People exposed to adverse childhood events, particularly those exposed to multiple stressors, died younger than those who were not exposed… some of this increase in risk is explained by related health and social problems.” Click here to read an article from ABC News that discusses these findings more.
Link to this post
October 13, 20095:38 pm
posted by Aric Thorpe, MHR
Pot smokers at risk for psychosis
According to a new study out of Sydney, Australia that was published in the September issue of PLoS Medicine, marijuana users should think twice before partaking as there is good evidence of psychosis related to chronic use. According to Louisa Degenhardt, PhD, of the University of New South Wales in Sydney, Australia, and colleagues, the relationship between cannabis and psychotic disorders was greatest among frequent users of the drug. Authors from Medpage Today summarized that researchers saying, “The evidence points to a …complex constellation of factors leading to the development of psychosis.” The researchers said, “This study has confirmed what a number of … longitudinal studies [have already suggested].” Click here to read an article from Medpage Today that discusses this study more.
Link to this post
|

"I knew if I didn't get help, I was in for trouble. The Renewal program gave me the tools I needed to get my life back in order and also helped me restore my relationship with God."
--Lori H

Rolf B. Gainer, Ph.D., Diplomate ABDA, is the Chief Executive Office at Brookhaven Hospital and the Vice President of Rehabilitation Institutes of America. Dr. Gainer has been involved in the design and operation of treatment programs since 1977.
Aric Thorpe, MHR, is Brookhaven Hospital's Pastoral Liaison Representative. He conducts the quarterly Minister's Lifeline series and provides mental health information to pastors and clergy.
Sarah McGee, BA, serves as the Community Education Provider for Brookhaven Hospital. She provides information on mental health and drug and alcohol treatment to healthcare professionals in Oklahoma and surrounding states.

Michael Mason- A versatile and prolific writer, Michael is the author of the book, "Head Cases: Stories of Brain Injury and Its Aftermath," and regularly delivers engaging talks and readings to audiences nationwide. Michael serves at Brookhaven Hospital as an advocate for individuals with brain injury.
Penny Rott, MS, is a brain injury case manager for the Neurologic Rehabilitation Institute at Brookhaven Hospital..
|